Detalles de la búsqueda
1.
Hyperfractionation compared with standard fractionation in intensity-modulated radiotherapy for patients with locally advanced recurrent nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial.
Lancet;
401(10380): 917-927, 2023 03 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-36842439
2.
Endoscopic surgery compared with intensity-modulated radiotherapy in resectable locally recurrent nasopharyngeal carcinoma: a multicentre, open-label, randomised, controlled, phase 3 trial.
Lancet Oncol;
22(3): 381-390, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33600761
3.
Cetuximab or nimotuzumab plus intensity-modulated radiotherapy versus cisplatin plus intensity-modulated radiotherapy for stage II-IVb nasopharyngeal carcinoma.
Int J Cancer;
141(6): 1265-1276, 2017 09 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28577306
4.
The elevated pretreatment platelet-to-lymphocyte ratio predicts poor outcome in nasopharyngeal carcinoma patients.
Tumour Biol;
36(10): 7775-87, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-25944165
5.
Structural analysis of tumor-related single amino acid mutations in human MxA protein.
Chin J Cancer;
34(12): 583-93, 2015 Sep 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-26411585
6.
Assessment of Prophylactic Internal Carotid Artery Management in Postradiation Nasopharyngeal Necrosis Patients.
Otolaryngol Head Neck Surg;
170(2): 447-456, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38104320
7.
A novel endoscopic nasopharyngectomy by low-temperature plasma radiofrequency ablation in localized recurrent nasopharyngeal carcinoma.
Head Neck;
46(2): 291-299, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37974339
8.
Clinical findings and imaging features of 67 nasopharyngeal carcinoma patients with postradiation nasopharyngeal necrosis.
Chin J Cancer;
32(10): 533-8, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-23816556
9.
Randomized study of sinusoidal chronomodulated versus flat intermittent induction chemotherapy with cisplatin and 5-fluorouracil followed by traditional radiotherapy for locoregionally advanced nasopharyngeal carcinoma.
Chin J Cancer;
32(9): 502-11, 2013 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-23816561
10.
Multi-trajectories of health-related quality of life and their associated factors in patients with nasopharyngeal carcinoma: A longitudinal study.
Radiother Oncol;
186: 109743, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37315581
11.
Fosaprepitant Weekly vs Every 3 Weeks for the Prevention of Concurrent Chemoradiotherapy-Induced Nausea and Vomiting: A Pilot Randomized Clinical Trial.
JAMA Netw Open;
6(7): e2326127, 2023 07 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-37498596
12.
Camrelizumab Plus Apatinib in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma: An Open-Label, Single-Arm, Phase II Study.
J Clin Oncol;
41(14): 2571-2582, 2023 05 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36735896
13.
Efficacy of sequential chemoradiotherapy combined with toripalimab in de novo metastatic nasopharyngeal carcinoma: A phase II trial.
Cell Rep Med;
4(11): 101279, 2023 11 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-37951218
14.
Camrelizumab plus famitinib in patients with recurrent or metastatic nasopharyngeal carcinoma treated with PD-1 blockade: data from a multicohort phase 2 study.
EClinicalMedicine;
61: 102043, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-37415845
15.
Endoscopic Nasopharyngectomy Combined With Internal Carotid Artery Pretreatment for Recurrent Nasopharyngeal Carcinoma.
Otolaryngol Head Neck Surg;
166(3): 490-497, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34182810
16.
Gemcitabine combined with apatinib and toripalimab in recurrent or metastatic nasopharyngeal carcinoma.
Med;
3(10): 664-681.e6, 2022 10 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-36041429
17.
Efficacy of local therapy to metastatic foci in nasopharyngeal carcinoma: large-cohort strictly-matched retrospective study.
Ther Adv Med Oncol;
14: 17588359221112486, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35860835
18.
Effect of Induction Chemotherapy With Paclitaxel, Cisplatin, and Capecitabine vs Cisplatin and Fluorouracil on Failure-Free Survival for Patients With Stage IVA to IVB Nasopharyngeal Carcinoma: A Multicenter Phase 3 Randomized Clinical Trial.
JAMA Oncol;
8(5): 706-714, 2022 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35323856
19.
The Effect of Prolonged Duration of Intensity Modulated Radiotherapy for Nasopharyngeal Carcinoma.
Front Oncol;
11: 648637, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34595104
20.
Biopsy of distant metastasis is not a significant prognostic factor for synchronous metastatic nasopharyngeal carcinoma: a propensity score-matched analysis from the Surveillance Epidemiology and End-Results Registry.
J Cancer;
12(14): 4424-4432, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34093843